Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks?

Self TH, Wallace JL, Soberman JE.

J Asthma. 2012 Nov;49(9):947-51. doi: 10.3109/02770903.2012.719252. Epub 2012 Sep 13.

PMID:
22974249
2.

Beta-blocker underuse in secondary prevention of myocardial infarction.

Everly MJ, Heaton PC, Cluxton RJ Jr.

Ann Pharmacother. 2004 Feb;38(2):286-93. Epub 2003 Dec 30. Review.

PMID:
14742768
3.

Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma.

Self T, Rogers ML, Mancell J, Soberman JE.

Am J Med Sci. 2011 Jul;342(1):56-61. doi: 10.1097/MAJ.0b013e3182087347. Review.

PMID:
21293248
4.

[Atenolol or metoprolol as beta-blocker in the treatment of hypertension].

van den Born BJ, Brewster LM, Koopmans RP, van Montfrans GA.

Ned Tijdschr Geneeskd. 2005 Aug 6;149(32):1808-9. Dutch.

PMID:
16121668
5.

Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma?

Chafin CC, Soberman JE, Demirkan K, Self T.

Cardiology. 1999;92(2):99-105. Review.

PMID:
10702651
6.

Atenolol and metoprolol once daily in hypertension.

Scott AK, Rigby JW, Webster J, Hawksworth GM, Petrie JC, Lovell HG.

Br Med J (Clin Res Ed). 1982 May 22;284(6328):1514-6.

7.
8.

Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.

Brooks TW, Creekmore FM, Young DC, Asche CV, Oberg B, Samuelson WM.

Pharmacotherapy. 2007 May;27(5):684-90.

PMID:
17461703
9.

Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

Salpeter SR, Ormiston TM, Salpeter EE.

Ann Intern Med. 2002 Nov 5;137(9):715-25.

PMID:
12416945
10.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838
11.

Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Heel RC, Brogden RN, Speight TM, Avery GS.

Drugs. 1979 Jun;17(6):425-60. Review.

PMID:
38096
13.

[Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].

Glaab T, Weiss T.

Internist (Berl). 2004 Feb;45(2):221-7. Review. German.

PMID:
14991165
15.

Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks?

Self T, Soberman JE, Bubla JM, Chafin CC.

J Asthma. 2003 Dec;40(8):839-45. Review. No abstract available.

PMID:
14736083
16.

The evolving role of β-adrenergic receptor blockers in managing hypertension.

Poirier L, Lacourcière Y.

Can J Cardiol. 2012 May;28(3):334-40. doi: 10.1016/j.cjca.2012.04.001. Review.

PMID:
22595449
18.

Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study.

Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Wester PO.

J Hypertens. 1992 Dec;10(12):1525-30.

PMID:
1338084
19.

Implication of different initial beta blockers on treatment persistence: atenolol vs new-generation beta blocker, a population-based study.

Choi YJ, Ah YM, Kong J, Choi KH, Kim B, Han N, Yu YM, Oh JM, Shin WG, Lee HY, Lee JY.

Cardiovasc Ther. 2016 Aug;34(4):268-75. doi: 10.1111/1755-5922.12197.

PMID:
27214564

Supplemental Content

Support Center